Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SINOPEC CORP
00386
| (FY)Dec 31, 2025 | (Q4)Dec 31, 2025 | (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -433.99%-13.17M | -285.14%-4.13M | -40.20%-3.89M | 23.89%-2.79M | -128.97%-2.36M | 265.01%3.94M | 178.31%2.23M | -29.18%-2.78M | -13.69%-3.66M | 39.92%8.15M |
| Net income from continuing operations | 192.45%4.38M | 2,057.66%14.7M | -1,640.77%-6.32M | -43.27%-1.68M | 5.50%-2.32M | 19.79%-4.74M | 53.53%-751K | 84.34%-363K | -944.60%-1.17M | -15.93%-2.45M |
| Operating gains losses | -2,234.55%-23.97M | -7,257.39%-25.9M | -112.15%-172K | 201.72%1.12M | -16.24%975K | 1,347.78%1.12M | -184.21%-352K | 15,833.33%1.42M | 23.42%-1.11M | 23.31%1.16M |
| Depreciation and amortization | 25.00%40K | -57.89%8K | --11K | -15.38%11K | --10K | --32K | --19K | --0 | --13K | --0 |
| Asset impairment expenditure | --788K | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Remuneration paid in stock | 475.97%8.77M | 435.69%3.93M | 2,677.52%3.58M | --171K | 64.55%1.09M | 34.42%1.52M | --734K | -89.83%129K | --0 | 594.74%660K |
| Other non cashItems | 441.52%2.43M | 2,062.50%1.9M | 130.58%511K | -99.62%7K | -97.56%5K | -63.55%448K | -64.94%88K | -779.27%-1.67M | 670.46%1.83M | -58.59%205K |
| Change In working capital | -200.85%-5.6M | -82.33%440K | 34.15%-1.51M | 24.95%-2.42M | -124.72%-2.12M | 757.56%5.56M | 231.19%2.49M | -71.05%-2.29M | -27.60%-3.22M | 33.83%8.58M |
| -Change in receivables | 457.14%25K | 900.00%8K | -101.92%-1K | 107.41%4K | 450.00%14K | 58.82%-7K | 94.44%-1K | 5,300.00%52K | -1,000.00%-54K | 0.00%-4K |
| -Change in prepaid assets | -223.88%-6.56M | -121.26%-576K | 31.51%-1.56M | 34.58%-2.1M | -128.67%-2.32M | 445.11%5.29M | 261.92%2.71M | -86.90%-2.28M | -33.82%-3.21M | 28.93%8.08M |
| -Change in payables and accrued expense | 219.47%968K | 610.55%1.02M | 221.05%69K | -632.76%-309K | -61.68%192K | 199.02%303K | 3.86%-199K | 50.43%-57K | 144.62%58K | 243.15%501K |
| -Change in other current liabilities | -25.00%-40K | 57.89%-8K | ---11K | 15.38%-11K | ---10K | ---32K | ---19K | --0 | ---13K | --0 |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -433.99%-13.17M | -285.14%-4.13M | -40.20%-3.89M | 23.89%-2.79M | -128.97%-2.36M | 265.01%3.94M | 178.31%2.23M | -29.18%-2.78M | -13.69%-3.66M | 39.92%8.15M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -13,575.71%-28.72M | -28.49M | 0 | -225K | 0 | 40.17%-210K | 0 | -1,933.33%-55K | 0 | -155K |
| Capital expenditure reported | -678.10%-1.63M | ---1.41M | --0 | ---225K | --0 | 42.47%-210K | --0 | -450.00%-55K | --0 | ---155K |
| Net PPE purchase and sale | ---3M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net business purchase and sale | ---24.09M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -13,575.71%-28.72M | ---28.49M | --0 | ---225K | --0 | 40.17%-210K | --0 | -1,933.33%-55K | --0 | ---155K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 1,752.32%36.25M | 9,736.62%27.94M | 7.38M | -77.80%240K | 17.57%696K | -46.89%1.96M | 3.27%284K | 0 | 1.08M | -82.62%592K |
| Net issuance payments of debt | 2,059.33%32.76M | 3,383.95%27.62M | --4.73M | --196K | 125.75%214K | -218.92%-1.67M | ---841K | --0 | --0 | -159.10%-831K |
| Net common stock issuance | -3.42%3.36M | -71.91%318K | --2.56M | --0 | -66.76%482K | 53.05%3.48M | 311.64%1.13M | --0 | --900K | -27.50%1.45M |
| Proceeds from stock option exercised by employees | -29.83%127K | --0 | --83K | ---- | ---- | 4,425.00%181K | --0 | --0 | ---- | ---- |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---34K | ---7K | --0 | --0 | ---27K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 1,752.32%36.25M | 9,736.62%27.94M | --7.38M | -77.80%240K | 17.57%696K | -46.89%1.96M | 3.27%284K | --0 | --1.08M | -82.62%592K |
| Net cash flow | ||||||||||
| Beginning cash position | 246.28%8M | 28.43%7.05M | -57.19%3.56M | -41.89%6.33M | 246.28%8M | 69.23%2.31M | 10.29%5.49M | 16.88%8.32M | 2.85%10.9M | 69.23%2.31M |
| Current changes in cash | -199.05%-5.64M | -286.43%-4.68M | 223.14%3.49M | -7.40%-2.77M | -119.40%-1.67M | 502.01%5.69M | 194.26%2.51M | -32.17%-2.83M | 25.83%-2.58M | -6.96%8.59M |
| End cash Position | -70.45%2.36M | -70.45%2.36M | 28.43%7.05M | -57.19%3.56M | -41.89%6.33M | 246.28%8M | 246.28%8M | 10.29%5.49M | 16.88%8.32M | 2.85%10.9M |
| Free cash from | -576.82%-17.8M | -482.81%-8.53M | -37.48%-3.89M | 17.75%-3.01M | -129.54%-2.36M | 235.51%3.73M | 175.78%2.23M | -31.13%-2.83M | -5.20%-3.66M | 37.26%8M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.